{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:17:50Z","timestamp":1768979870783,"version":"3.49.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.intimp.2022.109077","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T22:51:35Z","timestamp":1658875895000},"page":"109077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel insights into the relationship between \u03b1-1 anti-trypsin with the pathological development of cardio-metabolic disorders"],"prefix":"10.1016","volume":"111","author":[{"given":"Haizhen","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-415X","authenticated-orcid":false,"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2022.109077_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123701","article-title":"Inflammation-Accelerated Senescence and the Cardiovascular System: Mechanisms and Perspectives","volume":"19","author":"Del Pinto","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11154-020-09560-x","article-title":"Acromegaly, inflammation and cardiovascular disease: a review","volume":"21","author":"Wolters","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"10.1016\/j.intimp.2022.109077_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1570161118666200318104434","article-title":"Inflammatory Markers in Cardiovascular Disease Lessons Learned and Future Perspectives","volume":"19","author":"Patoulias","year":"2021","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109077_b0020","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes Dyslipidemia, and Nonalcoholic Fatty Liver Disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0025","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2022.109077_b0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clnesp.2019.12.001","article-title":"The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male","volume":"35","author":"Mansyur","year":"2020","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2022.109077_b0040","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.biopha.2018.09.138","article-title":"Gene therapy and type 1 diabetes mellitus","volume":"108","author":"Chellappan","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0045","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1210\/er.2019-00002","article-title":"Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease","volume":"40","author":"Donath","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.intimp.2022.109077_b0050","doi-asserted-by":"crossref","unstructured":"A. Moran, B. Bundy, D.J. Becker, L.A. DiMeglio, S.E. Gitelman, R. Goland, C.J. Greenbaum, K.C. Herold, J.B. Marks, P. Raskin, S. Sanda, D. Schatz, D.K. Wherrett, D.M. Wilson, J.P. Krischer, J.S. Skyler, G. Type 1 Diabetes TrialNet Canakinumab Study, L. Pickersgill, E. de Koning, A.G. Ziegler, B. Boehm, K. Badenhoop, N. Schloot, J.F. Bak, P. Pozzilli, D. Mauricio, M.Y. Donath, L. Castano, A. Wagner, H.H. Lervang, H. Perrild, T. Mandrup-Poulsen, A.S. Group, Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials, Lancet 381(9881) (2013) 1905\u20131915.","DOI":"10.1016\/S0140-6736(13)60023-9"},{"issue":"7","key":"10.1016\/j.intimp.2022.109077_b0055","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrendo.2013.103","article-title":"Therapy: Immunotherapy for T1DM\u2013targeting innate immunity","volume":"9","author":"Wong","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/joim.12239","article-title":"Role of alpha-1 antitrypsin in human health and disease","volume":"276","author":"de Serres","year":"2014","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.intimp.2022.109077_b0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/labinvest.3780324","article-title":"Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects","volume":"81","author":"Churg","year":"2001","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2022.109077_b0070","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4187\/respcare.05933","article-title":"Anti-Proteases and Alpha-1 Antitrypsin Augmentation Therapy","volume":"63","author":"Strange","year":"2018","journal-title":"Respir Care"},{"issue":"37","key":"10.1016\/j.intimp.2022.109077_b0075","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of alpha1-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9","key":"10.1016\/j.intimp.2022.109077_b0080","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","article-title":"Acute phase protein alpha1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses","volume":"211","author":"Kaner","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4049\/jimmunol.1101340","article-title":"alpha-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells","volume":"189","author":"Ozeri","year":"2012","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109077_b0090","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/db06-1273","article-title":"Alpha1-antitrypsin protects beta-cells from apoptosis","volume":"56","author":"Zhang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2022.109077_b0095","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","article-title":"alpha1-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.intimp.2022.109077_b0100","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2013.03.077","article-title":"Disorders of protein misfolding: alpha-1-antitrypsin deficiency as prototype","volume":"163","author":"Silverman","year":"2013","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1242\/dmm.014092","article-title":"Mysteries of alpha1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease","volume":"7","author":"Ghouse","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"8","key":"10.1016\/j.intimp.2022.109077_b0110","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2337\/diabetes.51.8.2642","article-title":"Insulin Resistance Atherosclerosis, Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study","volume":"51","author":"Hanley","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.intimp.2022.109077_b0115","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00592-016-0903-8","article-title":"Acute-phase proteins and incidence of diabetes: a population-based cohort study","volume":"53","author":"Muhammad","year":"2016","journal-title":"Acta Diabetol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109077_b0120","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Risk in Communities, Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2022.109077_b0125","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1038\/ncomms8754","article-title":"Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels","volume":"6","author":"Setoh","year":"2015","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2022.109077_b0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.20452\/pamw.536","article-title":"Assessment of alpha1-antitrypsin and alpha2-macroglobulin levels in obese patients","volume":"118","author":"Swiatkowska-Stodulska","year":"2008","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2022.109077_b0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000090933","article-title":"Elevated alpha1-antitrypsin is a risk factor for arterial ischemic stroke in childhood","volume":"115","author":"Burghaus","year":"2006","journal-title":"Acta Haematol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109077_b0140","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.STR.0000034787.02925.1F","article-title":"Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke","volume":"33","author":"Engstrom","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2022.109077_b0145","doi-asserted-by":"crossref","unstructured":"R. Malik, T. Dau, M. Gonik, A. Sivakumar, D.J. Deredge, E.V. Edeleva, J. Gotzfried, S.W. van der Laan, G. Pasterkamp, N. Beaufort, S. Seixas, S. Bevan, L.F. Lincz, E.G. Holliday, A.I. Burgess, K. Rannikmae, J. Minnerup, J. Kriebel, M. Waldenberger, M. Muller-Nurasyid, P. Lichtner, D. Saleheen, C. International Stroke Genetics, P.M. Rothwell, C. Levi, J. Attia, C.L. Sudlow, D. Braun, H.S. Markus, P.L. Wintrode, K. Berger, D.E. Jenne, M. Dichgans, Common coding variant in SERPINA1 increases the risk for large artery stroke, Proc. Natl. Acad. Sci. U S A 114(14) (2017) 3613\u20133618.","DOI":"10.1073\/pnas.1616301114"},{"issue":"8","key":"10.1016\/j.intimp.2022.109077_b0150","doi-asserted-by":"crossref","first-page":"10107","DOI":"10.1096\/fj.201903197R","article-title":"SERPINA1 gene expression in whole blood links the rs6647 variant G allele to an increased risk of large artery atherosclerotic stroke","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.intimp.2022.109077_b0155","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/01.CIR.0000017327.69909.FF","article-title":"Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men","volume":"105","author":"Engstrom","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2022.109077_b0160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/diabetes.52.2.442","article-title":"Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study","volume":"52","author":"Engstrom","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12933-018-0733-9","article-title":"Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis","volume":"17","author":"Bao","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2022.109077_b0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jocn.2020.04.074","article-title":"Serum alpha-1 antitrypsin in acute ischemic stroke: A prospective pilot study","volume":"76","author":"Mahta","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/1440-1681.12499","article-title":"Increased ratio of neutrophil elastase to alpha1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis","volume":"43","author":"Zang","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0185","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cmet.2013.03.005","article-title":"Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure","volume":"17","author":"Mansuy-Aubert","year":"2013","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.intimp.2022.109077_b0190","doi-asserted-by":"crossref","first-page":"e0222032","DOI":"10.1371\/journal.pone.0222032","article-title":"Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0195","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41598-020-58361-4","article-title":"Inhibition of Serine Protease Activity Protects Against High Fat Diet-Induced Inflammation and Insulin Resistance","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2022.109077_b0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.diabres.2006.06.020","article-title":"Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus","volume":"75","author":"Hashemi","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.intimp.2022.109077_b0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.gt.3302156","article-title":"Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice","volume":"11","author":"Song","year":"2004","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.intimp.2022.109077_b0210","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00125-005-1816-1","article-title":"Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells","volume":"48","author":"Bosco","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcb.10114","article-title":"Cytokine regulatory effects on alpha-1 proteinase inhibitor expression in NOD mouse islet endothelial cells","volume":"85","author":"Papaccio","year":"2002","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.intimp.2022.109077_b0220","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1515\/hsz-2014-0161","article-title":"Immune-modulating effects of alpha-1 antitrypsin","volume":"395","author":"Ehlers","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.intimp.2022.109077_b0225","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2016.00033","article-title":"Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance","volume":"22","author":"Toonen","year":"2016","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0230","doi-asserted-by":"crossref","first-page":"E560","DOI":"10.1152\/ajpendo.00181.2021","article-title":"alpha1-Antitrypsin A treatment attenuates neutrophil elastase accumulation and enhances insulin sensitivity in adipose tissue of mice fed a high-fat diet","volume":"321","author":"D'Souza","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.intimp.2022.109077_b0235","doi-asserted-by":"crossref","first-page":"E466","DOI":"10.1152\/ajpendo.00266.2012","article-title":"Inflammation during obesity is not all bad: evidence from animal and human studies","volume":"304","author":"Ye","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.intimp.2022.109077_b0240","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00125-014-3447-x","article-title":"IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice","volume":"58","author":"Westwell-Roper","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2022.109077_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.100984","article-title":"Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and beta-cell dysfunction","volume":"37","author":"Rodriguez-Comas","year":"2020","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2022.109077_b0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.devcel.2021.02.011","article-title":"Conversion of the death inhibitor ARC to a killer activates pancreatic beta cell death in diabetes","volume":"56","author":"McKimpson","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.intimp.2022.109077_b0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","article-title":"Immunogenetics of type 1 diabetes: A comprehensive review","volume":"64","author":"Noble","year":"2015","journal-title":"J. Autoimmun."},{"issue":"11","key":"10.1016\/j.intimp.2022.109077_b0260","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00125-018-4726-8","article-title":"Immunological biomarkers for the development and progression of type 1 diabetes","volume":"61","author":"Mathieu","year":"2018","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.intimp.2022.109077_b0265","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2337\/db12-1345","article-title":"Reduction of circulating neutrophils precedes and accompanies type 1 diabetes","volume":"62","author":"Valle","year":"2013","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.intimp.2022.109077_b0270","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2337\/db14-0480","article-title":"Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type 1 diabetes","volume":"63","author":"Wang","year":"2014","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.intimp.2022.109077_b0275","doi-asserted-by":"crossref","first-page":"e0182932","DOI":"10.1371\/journal.pone.0182932","article-title":"Identification of novel biomarkers to monitor beta-cell function and enable early detection of type 2 diabetes risk","volume":"12","author":"Belongie","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109077_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.12.004","article-title":"New emerging roles of the novel hepatokine SERPINB1 in type 2 diabetes mellitus: Crosstalk with beta-cell dysfunction and dyslipidemia","volume":"231","author":"Kamal","year":"2021","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0285","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/fsn3.1859","article-title":"Forkhead box protein O1 (FoxO1) \/SERPINB1 ameliorates ROS production in diabetic nephropathy","volume":"9","author":"Liang","year":"2021","journal-title":"Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.intimp.2022.109077_b0290","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13193","article-title":"Plasma serpinB1 is related to insulin sensitivity but not pancreatic beta-Cell function in non-diabetic adults","volume":"5","author":"Glicksman","year":"2017","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.intimp.2022.109077_b0295","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fendo.2020.00450","article-title":"A Novel SERPINB1 Single-Nucleotide Polymorphism Associated With Glycemic Control and beta-Cell Function in Egyptian Type 2 Diabetic Patients","volume":"11","author":"Kassem","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.intimp.2022.109077_b0300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4161\/isl.2.3.11654","article-title":"alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells","volume":"2","author":"Kalis","year":"2010","journal-title":"Islets"},{"issue":"42","key":"10.1016\/j.intimp.2022.109077_b0305","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1073\/pnas.0808031105","article-title":"Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice","volume":"105","author":"Koulmanda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9","key":"10.1016\/j.intimp.2022.109077_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091321","article-title":"Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes","volume":"8","author":"Ma","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2022.109077_b0315","article-title":"alpha1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet beta-cells in favor of protection from autoimmune diabetes","author":"Guttman","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109077_b0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12931-021-01890-x","article-title":"alpha1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts","volume":"22","author":"Nakagiri","year":"2021","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109077_b0325","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/sctm.20-0122","article-title":"Overexpression of alpha-1 antitrypsin in mesenchymal stromal cells improves their intrinsic biological properties and therapeutic effects in nonobese diabetic mice","volume":"10","author":"Song","year":"2021","journal-title":"Stem Cells Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109077_b0330","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/pedi.12660","article-title":"Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics","volume":"19","author":"Weir","year":"2018","journal-title":"Pediatr. Diabetes"},{"issue":"13","key":"10.1016\/j.intimp.2022.109077_b0335","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2217\/imt-2018-0047","article-title":"Long-term safety of alpha-1 antitrypsin therapy in children and adolescents with Type 1 diabetes","volume":"10","author":"Brener","year":"2018","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.intimp.2022.109077_b0340","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/pedi.12283","article-title":"Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus","volume":"17","author":"Rachmiel","year":"2016","journal-title":"Pediatr Diabetes"},{"issue":"23","key":"10.1016\/j.intimp.2022.109077_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236032","article-title":"Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia((R))) in the Treatment of Recent-Onset Type 1 Diabetes","volume":"20","author":"Lebenthal","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2022.109077_b0350","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2174\/1871530320666201208110945","article-title":"Tarkeshwer, Evaluation of Gamma Amino Butyric Acid (GABA) and Glibenclamide Combination Therapy in Streptozotocin Induced Diabetes","volume":"21","author":"Zhu","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.intimp.2022.109077_b0355","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221098038","article-title":"Local Dexamethasone Administration Delays Allogeneic Islet Graft Rejection in the Anterior Chamber of the Eye of Non-Human Primates","volume":"31","author":"Tun","year":"2022","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2022.109077_b0360","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2337\/db16-1036","article-title":"alpha-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction","volume":"66","author":"Wang","year":"2017","journal-title":"Diabetes"},{"issue":"38","key":"10.1016\/j.intimp.2022.109077_b0365","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1073\/pnas.1018366109","article-title":"Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival","volume":"109","author":"Koulmanda","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"42","key":"10.1016\/j.intimp.2022.109077_b0370","doi-asserted-by":"crossref","first-page":"16236","DOI":"10.1073\/pnas.0807627105","article-title":"alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice","volume":"105","author":"Lewis","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"34","key":"10.1016\/j.intimp.2022.109077_b0375","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1073\/pnas.0505579102","article-title":"Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice","volume":"102","author":"Lewis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"5","key":"10.1016\/j.intimp.2022.109077_b0380","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/ajt.16342","article-title":"Alpha-1 antitrypsin suppresses macrophage activation and promotes islet graft survival after intrahepatic islet transplantation","volume":"21","author":"Gou","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2022.109077_b0385","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/0717-6287-47-58","article-title":"Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?","volume":"47","author":"Ortiz","year":"2014","journal-title":"Biol. Res."},{"issue":"12","key":"10.1016\/j.intimp.2022.109077_b0390","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00125-019-04998-4","article-title":"Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy","volume":"62","author":"Liu","year":"2019","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.intimp.2022.109077_b0395","doi-asserted-by":"crossref","first-page":"e0228895","DOI":"10.1371\/journal.pone.0228895","article-title":"Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy","volume":"15","author":"Potilinski","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109077_b0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.exer.2018.05.013","article-title":"Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina","volume":"174","author":"Ortiz","year":"2018","journal-title":"Exp. Eye Res."},{"issue":"13","key":"10.1016\/j.intimp.2022.109077_b0405","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.62.13.7","article-title":"Neutrophil-Derived Proteases Contribute to the Pathogenesis of Early Diabetic Retinopathy","volume":"62","author":"Lessieur","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2022.109077_b0410","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12967-015-0712-9","article-title":"Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS\/MS and iTRAQ quantification","volume":"13","author":"Guo","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2022.109077_b0415","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2147\/DMSO.S250347","article-title":"Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria","volume":"13","author":"Ning","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"12","key":"10.1016\/j.intimp.2022.109077_b0420","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:54:11Z","timestamp":1761587651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":84,"alternative-id":["S1567576922005616"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109077","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into the relationship between \u03b1-1 anti-trypsin with the pathological development of cardio-metabolic disorders","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109077"}}